Needle-Free Diabetes Care Market Size, Share, Trends & Analysis By Type, Regional Outlook, Industry Insights, Key Players, Applications And Forecast To 2028

Report Summary

Eternity Insights has published a new study on Global Needle-Free Diabetes Care Market focusing on key segments as by Type (Insulin Patches, Jet Injectors, Insulin Pens, Insulin Pumps, Insulin Infuser), by Application (Consumer, Diagnostic Centers, Hospitals and Clinics, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Needle-Free Diabetes Care Market.

The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.

Needle-Free Diabetes Care Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Global Needle-Free Diabetes Care Market Size, 2018-2028 (USD Million)

To learn more about this report

Request For Sample

Global Needle-Free Diabetes Care Market Segmentation:

Needle-Free Diabetes Care Market, By Type

• Insulin Patches
• Jet Injectors
• Insulin Pens
• Insulin Pumps
• Insulin Infuser

Needle-Free Diabetes Care Market, By Application

• Consumer
• Diagnostic Centers
• Hospitals and Clinics
• Other

To learn more about this report

Request For Sample

Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Needle-Free Diabetes Care market in terms of demand generation. The Needle-Free Diabetes Care market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Needle-Free Diabetes Care market for below listed coun-tries across each region.

North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).

Global Needle-Free Diabetes Care Market Taxonomy:

To learn more about this report

Request For Sample

Global Needle-Free Diabetes Care Market Competitive Landscape

The global Needle-Free Diabetes Care market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details

• Company Overview
• Financial Analysis
• Product Portfolio Analysis
• Strategic Overview
• SWOT Analysis

List of Companies Profiled in the report:

• Antares Pharma
• European Pharma Group
• Johnson and Johnson
• Injex UK
• Echo Therapeutics
• MannKind Corporation
• Other Players of Specific Interest can be added based on requirement

Market Segmentation

Report Attributes	Details
The market size value in 2021	USD XX.XX Million
CAGR (2021 - 2028)	XX.XX %
The Revenue forecast in 2028	USD XX.XX Million
Base year for estimation	2021
Historical data	2018-2019
Forecast period	2022-2028
Quantitative units	Revenue in USD Million CAGR from 2021 to 2028
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	By Type Outlook, Application Outlook, Regional Outlook
By Type Outlook	Insulin Patches, Jet Injectors, Insulin Pens, Insulin Pumps, Insulin Infuser
By Application Outlook	Consumer, Diagnostic Centers, Hospitals and Clinics, Other
Regional scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope	U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey
Key companies profiled	Antares Pharma, European Pharma Group, Johnson and Johnson, Injex UK, Echo Therapeutics, MannKind Corporation
Customization Available	Yes, the report can be tailored to meet your specific requirements.

Key Benefits to the stake holders

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come

Table Of Contents

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Needle-Free Diabetes Care Market Size Growth Rate by Type (2017-2027)
1.4.2 Insulin Patches
1.4.3 Jet Injectors
1.4.4 Insulin Pens
1.4.5 Insulin Pumps
1.4.6 Insulin Infuser
1.5 Market by Application
1.5.1 Global Needle-Free Diabetes Care Market Share by Application (2017-2027)
1.5.2 Consumer
1.5.3 Diagnostic Centers
1.5.4 Hospitals and Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Needle-Free Diabetes Care Market Size
2.2 Needle-Free Diabetes Care Growth Trends by Regions
2.2.1 Needle-Free Diabetes Care Market Size by Regions (2017-2027)
2.2.2 Needle-Free Diabetes Care Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Needle-Free Diabetes Care Market Size by Manufacturers
3.1.1 Global Needle-Free Diabetes Care Revenue by Manufacturers (2017-2020)
3.1.2 Global Needle-Free Diabetes Care Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Needle-Free Diabetes Care Market Concentration Ratio (CR5 and HHI)
3.2 Needle-Free Diabetes Care Key Players Head office and Area Served
3.3 Key Players Needle-Free Diabetes Care Product/Solution/Service
3.4 Date of Enter into Needle-Free Diabetes Care Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Needle-Free Diabetes Care Market Size by Type (2017-2020)
4.2 Global Needle-Free Diabetes Care Market Size by Application (2017-2020)

5 United States
5.1 United States Needle-Free Diabetes Care Market Size (2017-2020)
5.2 Needle-Free Diabetes Care Key Players in United States
5.3 United States Needle-Free Diabetes Care Market Size by Type
5.4 United States Needle-Free Diabetes Care Market Size by Application

6 Europe
6.1 Europe Needle-Free Diabetes Care Market Size (2017-2020)
6.2 Needle-Free Diabetes Care Key Players in Europe
6.3 Europe Needle-Free Diabetes Care Market Size by Type
6.4 Europe Needle-Free Diabetes Care Market Size by Application

7 China
7.1 China Needle-Free Diabetes Care Market Size (2017-2020)
7.2 Needle-Free Diabetes Care Key Players in China
7.3 China Needle-Free Diabetes Care Market Size by Type
7.4 China Needle-Free Diabetes Care Market Size by Application

8 Japan
8.1 Japan Needle-Free Diabetes Care Market Size (2017-2020)
8.2 Needle-Free Diabetes Care Key Players in Japan
8.3 Japan Needle-Free Diabetes Care Market Size by Type
8.4 Japan Needle-Free Diabetes Care Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Needle-Free Diabetes Care Market Size (2017-2020)
9.2 Needle-Free Diabetes Care Key Players in Southeast Asia
9.3 Southeast Asia Needle-Free Diabetes Care Market Size by Type
9.4 Southeast Asia Needle-Free Diabetes Care Market Size by Application

10 India
10.1 India Needle-Free Diabetes Care Market Size (2017-2020)
10.2 Needle-Free Diabetes Care Key Players in India
10.3 India Needle-Free Diabetes Care Market Size by Type
10.4 India Needle-Free Diabetes Care Market Size by Application

11 Central & South America
11.1 Central & South America Needle-Free Diabetes Care Market Size (2017-2020)
11.2 Needle-Free Diabetes Care Key Players in Central & South America
11.3 Central & South America Needle-Free Diabetes Care Market Size by Type
11.4 Central & South America Needle-Free Diabetes Care Market Size by Application

12 International Players Profiles
12.1 Antares Pharma
12.1.1 Antares Pharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Needle-Free Diabetes Care Introduction
12.1.4 Antares Pharma Revenue in Needle-Free Diabetes Care Business (2017-2020)
12.1.5 Antares Pharma Recent Development
12.2 European Pharma Group
12.2.1 European Pharma Group Company Details
12.2.2 Company Description and Business Overview
12.2.3 Needle-Free Diabetes Care Introduction
12.2.4 European Pharma Group Revenue in Needle-Free Diabetes Care Business (2017-2020)
12.2.5 European Pharma Group Recent Development
12.3 Johnson and Johnson
12.3.1 Johnson and Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Needle-Free Diabetes Care Introduction
12.3.4 Johnson and Johnson Revenue in Needle-Free Diabetes Care Business (2017-2020)
12.3.5 Johnson and Johnson Recent Development
12.4 Injex UK
12.4.1 Injex UK Company Details
12.4.2 Company Description and Business Overview
12.4.3 Needle-Free Diabetes Care Introduction
12.4.4 Injex UK Revenue in Needle-Free Diabetes Care Business (2017-2020)
12.4.5 Injex UK Recent Development
12.5 Echo Therapeutics
12.5.1 Echo Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Needle-Free Diabetes Care Introduction
12.5.4 Echo Therapeutics Revenue in Needle-Free Diabetes Care Business (2017-2020)
12.5.5 Echo Therapeutics Recent Development
12.6 MannKind Corporation
12.6.1 MannKind Corporation Company Details
12.6.2 Company Description and Business Overview
12.6.3 Needle-Free Diabetes Care Introduction
12.6.4 MannKind Corporation Revenue in Needle-Free Diabetes Care Business (2017-2020)
12.6.5 MannKind Corporation Recent Development

13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details